Market Cap (In TWD)
242.64 Million
Revenue (In TWD)
172.46 Million
Net Income (In TWD)
6.43 Million
Avg. Volume
37.83 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 14.7-24.6
- PE
- -
- EPS
- -
- Beta Value
- 0.065
- ISIN
- TW0006848005
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Yen-Liang Chen
- Employee Count
- -
- Website
- https://www.rbcbioscience.com
- Ipo Date
- 2021-10-25
- Details
- RBC Bioscience Corporation researches, develops, manufactures, and sells reagents and devices for life science and molecular diagnosis in Europe, the United States, Asia, Taiwan, Africa, and Australia. It offers molecular biomedical diagnostic and research reagents, gene extraction automatic testing instruments, and gene extraction reagent tissues; automated nucleic acid extractors; and nucleic acid extraction kits. The company sells its products through distributors. RBC Bioscience Corporation was founded in 1995 and is based in New Taipei City, Taiwan.
More Stocks
-
4379Photosynth inc.
4379
-
2754
-
0410SOHO China Limited
0410
-
CNACentrica plc
CNA
-
9065Sankyu Inc.
9065
-
9248
-
0670
-
ERDLFEROAD Limited
ERDLF